Corpus Intelligence IC Memo — HOWARD MEMORIAL HOSPITAL 2026-04-26 04:04 UTC
IC Memo — HOWARD MEMORIAL HOSPITAL
Investment Committee Memorandum | AR | 20 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HOWARD MEMORIAL HOSPITAL

CCN 041311 | HOWARD, AR | 20 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HOWARD MEMORIAL HOSPITAL is a 20-bed rural/critical access in HOWARD, AR with $26.5M in net patient revenue and a -15.8% operating margin. The hospital serves a payer mix of 55.4% Medicare, 6.6% Medicaid, and 37.9% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.8% to -8.4% (+736bps).

Net Revenue HCRIS$26.5M
Current EBITDA COMPUTED$-4.2M
Operating Margin COMPUTED-15.8%
Occupancy HCRIS31.6%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS35.2%
Distress Probability ML54.4%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
49
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -15.8% places it below the state median. Among 49 size-comparable peers (10-40 beds), the median margin is -13.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 49 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HOWARD MEMORIAL HOSPITAL (Target)AR20$26.5M-15.8%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
BAPTIST HEALTH MED CTR ARKADELAR25$30.1M-3.1%
MAGNOLIA REGIONAL HEALTH SYSTEAR29$25.9M-21.3%
BHMC-HEBER SPRINGSAR25$25.4M-4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$557K+210bp18mo
Cost to Collect4.5%2.5%$530K+200bp12mo
Denial Rate Reduction12.0%6.5%$525K+198bp12mo
A/R Days Reduction5200.0%3800.0%$323K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$557K
Cost to Collect
$530K
Denial Rate Reduction
$525K
A/R Days Reduction
$323K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$-4.2M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$-2.2M
Current Margin-15.8%
Pro Forma Margin-8.4%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.4M$-8.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.4M$-11.0M0.00x-100.0%
Bull Case9.0x11.0x$-5.8M$-6.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.8M$-9.0M0.00x-100.0%
Bear Case11.0x10.0x$-7.1M$-15.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.1M$-19.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 55.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 31.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 49 hospitals with 10-40 beds
  • Same-state prioritization (n=50)
  • Comp margins: P25=-23.7% / P50=-13.9% / P75=-1.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.